Discussion  by unknown
JOURNAL OF VASCULAR SURGERY
1264 Skrepnek et al November 2014AUTHOR CONTRIBUTIONS
Conception and design: GS, DA, JM
Analysis and interpretation: GS, DA, JM
Data collection: GS
Writing the article: GS, DA, JM
Critical revision of the article: GS, DA, JM
Final approval of the article: GS, DA, JM
Statistical analysis: GS, DA, JM
Obtained funding: Not applicable
Overall responsibility: GS
REFERENCES
1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients
with diabetes. JAMA 2005;293:217-28.
2. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS,
Lipsky BA. Risk factors for foot infections in individuals with diabetes.
Diabetes Care 2006;29:1288-93.
3. Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetes-
related wounds and amputations worse than cancer? Int Wound J
2007;4:286-7.
4. ArmstrongDG,Mills JL. Toward a change in syntax in diabetic foot care:
prevention equals remission. J Am Podiatr Med Assoc 2013;103:161-2.
5. DriverVR, FabbiM,LaveryLA,GibbonsG.The costs of diabetic foot: the
economic case for the limb salvage team. J Vasc Surg 2010;52:17S-22S.
6. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National
trends in lower extremity bypass surgery, endovascular interventions,
and major amputations. J Vasc Surg 2009;50:54-60.
7. Egorova NN, Guillerme S, Gelijns A, Morrissey N, Dayal R,
McKinsey JF, et al. An analysis of the outcomes of a decade of expe-
rience with lower extremity revascularization including limb salvage,
lengths of stay, and safety. J Vasc Surg 2010;51:878-85. 885.
8. Eslami MH, Zayaruzny M, Fitzgerald GA. The adverse effects of race,
insurance status, and low income on the rate of amputation in
patients presenting with lower extremity ischemia. J Vasc Surg
2007;45:55-9.
9. Cull DL, Langan EM, Gray BH, Johnson B, Taylor SM. Open versus
endovascular intervention for critical limb ischemia: a population-based
study. J Am Coll Surg 2010;210:555-61.
10. Anderson PL, Gelijns A, Moskowitz A, Arons R, Gupta L, Weinberg A,
et al. Understanding trends in inpatient surgical volume: vascular in-
terventions, 1980-2000. J Vasc Surg 2004;39:1200-8.
11. AHRQ, Agency for Healthcare Research and Quality. Introduction to
the HCUP Nationwide Inpatient Sample (NIS) 2010. Available at:
http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_
2010.jsp. Accessed May 5, 2013.
12. Sohn MW, Budiman-Mak E, Stuck RM, Siddiqui F, Lee TA. Diag-
nostic accuracy of existing methods for identifying diabetic foot ulcers
from inpatient and outpatient datasets. J Foot Ankle Res 2010;3:27.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co-morbidity
index for use with ICD-9-CM administrative databases. J Clin Epi-
demiol 1992;45:613-9.
14. Skrepnek GH, Olvey EL, Sahai A. Econometric approaches in evalu-
ating cost and utilization within pharmacoeconomic analyses. Pharm
Policy Law 2012;14:105-22.
15. Skrepnek GH. Regression methods in the empirical analysis of health
care data. J Manag Care Pharm 2005;11:240-51.
16. Simes RJ. An improved Bonferroni procedure for multiple tests of
signiﬁcance. Biometrika 1986;73:751-4.17. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease:
morbidity and mortality implications. Circulation 2006;114:688-99.
18. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA,
Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the
management of patients with peripheral arterial disease (lower ex-
tremity, renal, mesenteric, and abdominal aortic): a collaborative report
from the American Association for Vascular Surgery/Society for
Vascular Surgery, Society for Cardiovascular Angiography and In-
terventions, Society for Vascular Medicine and Biology, Society of
Interventional Radiology, and the ACC/AHA Task Force on Practice
Guidelines (Writing Committee to Develop Guidelines for the Man-
agement of Patients With Peripheral Arterial Disease): endorsed by the
American Association of Cardiovascular and Pulmonary Rehabilitation;
National Heart, Lung, and Blood Institute; Society for Vascular
Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease
Foundation. Circulation 2006;113:e463-654.
19. Dick F, Diehm N, Galimanis A, Husmann M, Schmidli JN,
Baumgartner I. Surgical or endovascular revascularization in patients
with critical limb ischemia: inﬂuence of diabetes mellitus on clinical
outcome. J Vasc Surg 2007;45:751-61.
20. Asaw S, Karkos CD, Serrachino-Inglott F, Cooper NJ, Butterﬁeld JS,
Ashleigh R, et al. The impact of diabetes on current revascularization
practice and clinical outcome in patients with critical lower limb
ischemia. Eur J Vasc Endovasc Surg 2006;32:51-9.
21. Skrepnek GH, Mills J, Armstrong DG. The inpatient burden of dia-
betic foot disease. Presented at: 73rd Scientiﬁc Sessions, American
Diabetes Association, Chicago, IL, June 21-25, 2013.
22. Nguyen LL, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL,
Belkin M, et al. Resource utilization in the treatment of critical limb
ischemia: the effect of tissue loss, comorbidities, and graft-related
events. J Vasc Surg 2006;44:971-6.
23. Kazmers A, Jacobs LA, Perkins AJ. Outcomes after lower-extremity
reconstruction in DRGs 478 and 479. J Surg Res 2000;88:18-22.
24. Durham CA, Mohr MC, Parker FM, Bogey WM, Powell CS,
Stoner MC. The impact of socioeconomic factors on outcome and
hospital costs associated with femoropopliteal revascularization. J Vasc
Surg 2010;52:600-7.
25. Kröger K, Dragano N, Stang A, Moebus S, Möhlenkamp S, Mann K,
et al. An unequal social distribution of peripheral arterial disease and the
possible explanations: results from a population-based study. Vasc Med
2009;14:289-96.
26. Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK,
Kucken LE, et al. Effects of race and income on mortality and use
of services among Medicare beneﬁciaries. N Engl J Med 1996;335:
791-9.
27. Agabiti N, Cesaroni G, Picciotto S, Bisanti L, Caranci N, Costa G, et al.
The association of socioeconomic disadvantage with postoperative
complications after major elective cardiovascular surgery. J Epidemiol
Community Health 2008;62:882-9.
28. Rowe VL, Kumar SR, Glass H, Hood DB, Weaver FA. Race inde-
pendently impacts outcome of infrapopliteal bypass for symptomatic
arterial insufﬁciency. Vasc Endovascular Surg 2007;41:397-401.
29. Goodney PP, Holman K, Henke PK, Travis LL, Dimick JB, Stukel TA,
et al. Regional intensity of vascular care and lower extremity amputa-
tion rates. J Vasc Surg 2013;57:1471-80.
30. Mills JL, Conte MS, Armstrong DG, Pomposelli F, Schanzer A,
Sidawy AN, et al. The Society for Vascular Surgery Lower Extremity
Threatened Limb Classiﬁcation System: risk stratiﬁcation based on
wound, ischemia and foot infection (WIfI). J Vasc Surg 2014;59:
220-34.
Submitted Feb 10, 2014; accepted Apr 29, 2014.DISCUSSIONDr Vincent Rowe (Los Angeles, Calif). The authors’ objective
was to review and report the charges, case complexity, and use of
revascularization among inpatient hospital admissions for diabetic
foot ulcers and associated amputations in the United States overthe past 10 years. To do so, the authors utilized the inpatient
discharge records from the Agency for Healthcare Research and
Quality Healthcare Cost and Utilization Project. The authors do
an excellent job of sorting out such a large volume of information
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complications. With such large databases, there are pros and
cons to the information that is accrued; however, the authors
clearly point out the shortcomings of this database, and therefore
there is no need for me to address those issues. My questions will
mainly be focused on the interpretation of their ﬁndings.
Over the past decade, patients with diabetic foot ulcers had a
shortened length of stay and increased hospital charges. What do
the authors attribute to this ﬁnding? Is it a reﬂection of increased
healthcare costs, are we driving up the costs with increased endo-
vascular procedures, or are the cases becoming more complex?
Dr Grant H. Skrepnek. Healthcare costs are an important
proxy that reﬂect the intensity of interventions and resources pro-
vided in clinical practice. The observation of increased charges with
decreased lengths of stay is complex and suggests, at least superﬁ-
cially, an increasing extent of inpatient care that allows patients to
be discharged more rapidly. Despite this, the current study’s out-
comes also reﬂect other dimensions, including the adoption of
medical technologies, evolving standards of care, price inﬂation,
and changes in patient case-mix. In this context, signiﬁcant in-
creases in the overall case-mix complexity were indeed observed
via either the Elixhauser or Deyo-Charlson Comorbidity Index.
However, a key limitation in most nationally representative data-
base work involves the lack of speciﬁc diabetic foot ulcer (DFU)-
related risk factors that capture the degree of ischemia, severity
of infection (if present), and other wound characteristics. While
either the diffusion of endovascular procedures or the increase in
overall case-complexity may indeed explain an observation of
increased charges, ceteris parabis, large-scale longitudinal analyses
incorporating these disease-speciﬁc measures would be helpful in
determining the comparative effectiveness of vascular interven-
tions. Finally, although not measured in the current work, the
quality of ambulatory care would intuitively be expected to inﬂu-
ence the potential outcomes within the hospital setting.
Dr Rowe. Did the authors see any difference in complications
and amputations when comparing patients treated in urban large
hospitals versus smaller hospitals?
Dr Skrepnek. Empirically, no systematic differences between
outcomes based on hospital bed size were observed. A ﬁnding thatmay deserve further investigation, however, involves the observa-
tion that lower odds of complications were found in urban (vs ru-
ral) hospitals among endovascular procedures: a 57% reduction in
the odds of complications for cases involving above-ankle amputa-
tions (OR, 0.43; 95% CI, 0.25-0.74; P ¼ .002), and a 32% reduc-
tion involving cases with no amputation (OR, 0.68; 95% CI, 0.49-
0.94; P ¼ .018). While higher charges were often associated with
urban hospitals, this was not necessarily observed across all proce-
dure types or amputation status.
Dr Rowe. Focusing on amputations, the authors state that the
amputation rates are ﬂattening?This is an intriguing issue, as there are
somany factors that can contribute to this clinical ﬁnding.Do the au-
thors think that the rise in endovascular procedures and minor inter-
ventions in an indicator ormarker of increased physician awareness of
the need for specialty (vascular) care of this diabetic population?
Dr Skrepnek. While the number of inpatient cases involving
diabetes has increased from 2001 to 2010, the percentage of those
with DFUs has remained constant, slightly below 4%. Also un-
changed through the decade, approximately 17% of inpatient
DFU cases involved amputations, 9% of DFU cases involve a revas-
cularization procedure, and 24% of revascularized DFU cases
involved an amputation. Despite these observations, an increase
in minor amputations occurred (from 8% to 12% of DFU cases
during the decade), with no change in major above-ankle amputa-
tions (9%-10% of DFU cases). The association between these latter
outcomes and an increase in endovascular interventions (from un-
der 5% of DFU cases to almost 15%) is compelling. While we sup-
port, at least anecdotally, that an increased clinical awareness
surrounding the care of the diabetic foot has occurred, we also
assert that insufﬁcient resources still remain concerning prevention.
Overall, estimates of the economic and clinical burden of illness
associated with DFUs should seek to increase awareness of the
condition, to enhance comparative and cost-effectiveness analyses
of treatment options, and to catalyze the prioritization of clinical
and research efforts to improve prevention and cure.
Dr Rowe. Thank you, Society, for selecting me to review this
interesting manuscript.
Dr Skrepnek. The authors are also appreciative of the
thoughtful and engaging evaluation of this work.
